mRNA疫苗让部分胰腺癌患者三年无复发 ...

Why not all African countries should venture into vaccine business ANALYSIS | The African Union has embarked on one of its ...

What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...

The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...

WASHINGTON, April 3, 2025 (BSS/AFP) - The US drug regulator has missed a deadline for granting full approval to Novavax's ...

In a legal battle between BioNTech and CureVac, the European Patent Office declared a patent owned by CureVac ...

Vaccine stocks are down after the health agency's top immunization official announced the move Monday, citing Secretary ...

CureVac's amended patent survives BioNTech's challenge as EPO upholds validity. A German court will decide on infringement in ...

As we previously discussed, beginning in 2022, a series of patent infringement lawsuits were filed against Moderna and ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $152.57, a high ...

Novavax (NVAX), and BioNTech (BNTX) (BTNX), and gene therapy developers, including Sarepta (SRPT), Solid Biosciences (SLDB), Taysha Gene Therapies (TSHA), Capricor Therapeutics (CAPR), and Crispr ...